|
🐜
|
Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis.
7 auth.
Fabrice Bonnet,
C. Deprele,
A. Sassolas,
P. Moulin,
E. Alamartine,
F. Berthezène,
...
F. Berthoux
|
8 |
2001 |
8
🐜
|
|
🐜
|
Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with Type II diabetes
7 auth.
S. Bernard,
S. Touzet,
I. Personne,
V. Lapras,
P. Bondon,
F. Berthezène,
...
Philippe Moulin
|
7 |
2000 |
7
🐜
|
|
🐜
|
Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects.
8 auth.
S. Bernard,
A. Sérusclat,
F. Targe,
S. Charrière,
O. Roth,
J. Beaune,
...
F. Berthezène,
P. Moulin
|
7 |
2005 |
7
🐜
|
|
🐢
|
Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency.
11 auth.
F. Borson‐Chazot,
A. Sérusclat,
Yadh Kalfallah,
X. Ducottet,
G. Sassolas,
Sophie Bernard,
...
F. Labrousse,
Jorge Pastene,
A. Sassolas,
Yves Roux,
F. Berthezène
|
7 |
1999 |
7
🐢
|
|
🐜
|
PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.
13 auth.
S. Vallette-Kasic,
A. Barlier,
C. Teinturier,
A. Díaz,
M. Manavela,
F. Berthezène,
P. Bouchard,
J. Chaussain,
R. Brauner,
I. Pellegrini-Bouiller,
...
P. Jaquet,
A. Enjalbert,
T. Brue
|
6 |
2001 |
6
🐜
|
|
🦁
|
Leydig-cell agenesis: a cause of male pseudohermaphroditism.
F. Berthezène,
M. Forest,
J. Grimaud,
B. Claustrat,
R. Mornex
|
6 |
1976 |
6
🦁
|
|
🐜
|
Erratum to: Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
11 auth.
S. Kumar,
A. Boulton,
H. Beck-Nielsen,
F. Berthezène,
M. Muggeo,
B. Persson,
...
G. Spinas,
S. Donoghue,
S. Lettis,
P. Stewart-Long,
T. S. Group
|
6 |
1996 |
6
🐜
|
|
🐬
|
Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome
F. Bonnet,
K. Irving,
J. Terra,
P. Nony,
F. Berthezène,
P. Moulin
|
6 |
2005 |
6
🐬
|
|
🐬
|
Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia.
M. Guerin,
P. Dolphin,
C. Talussot,
J. Gardette,
F. Berthezène,
M. Chapman
|
6 |
1995 |
6
🐬
|
|
🐜
|
Hypoparathyroidism during pregnancy: treatment with calcitriol.
8 auth.
B. Salle,
F. Berthezène,
F. Glorieux,
E. Delvin,
M. Berland,
L. David,
...
J. Varenne,
G. Putet
|
6 |
1981 |
6
🐜
|
